Birth control pills are classified by international cancer research authorities as a Group 1 carcinogen for certain cancers, yet the overall medical evidence shows they also reduce the risk of several other major cancers and remain a safe and widely used contraceptive method for most people.
This topic has gone viral on social media platforms such as Facebook and TikTok after claims circulated that the World Health Organisation recently declared birth control to cause cancer. The classification referenced in these posts is not new. It originates from cancer research evaluations conducted years earlier and has been discussed in medical literature for decades. The nuance of the classification is often lost in viral posts, which present a complex scientific assessment as a sudden announcement or warning.
Medical research shows that hormonal contraception can slightly increase the risk of a small number of cancers while lowering the risk of others, including ovarian and endometrial cancers. For most users the absolute risk remains low, particularly when compared with the health risks associated with pregnancy or smoking. This article explains the scientific classification, the history behind the research, the cancers involved, and how the benefits and risks compare. It also examines alternative birth control options and what individuals should consider when choosing a contraceptive method.
Key Takeaways
- Hormonal birth control is classified as a Group 1 carcinogen for certain cancers by international cancer researchers.
- The classification has existed for years and did not originate from a new WHO announcement.
- Hormonal contraception increases risk of some cancers but lowers risk of others.
- For most people the overall cancer risk associated with birth control remains small.
- Many effective non-hormonal contraceptive options are available.
Why the “birth control causes cancer” claim went viral
The recent wave of posts circulating online claims that the World Health Organisation announced that birth control causes cancer and placed it in the same risk category as smoking or asbestos. In reality, the statement refers to a scientific classification made by the cancer research arm of the World Health Organisation.
The body responsible for this classification is the International Agency for Research on Cancer (IARC), which evaluates evidence linking substances or exposures to cancer. IARC groups exposures according to the strength of scientific evidence.
Combined oral contraceptives have been classified in Group 1, which indicates that there is sufficient evidence that the exposure can cause cancer in humans. Smoking, asbestos and alcohol are also in Group 1. The classification refers only to evidence of causation for at least one cancer type. It does not measure the size of the risk.
This distinction is central to understanding the controversy. Group 1 means evidence exists that the exposure can cause cancer under some circumstances. It does not mean the risk is comparable to smoking or asbestos. Many everyday exposures fall into the same category, including alcohol and processed meat.
The recent viral claims therefore represent a misunderstanding of a long-standing scientific classification rather than a new warning issued by global health authorities.
The history of research linking birth control and cancer
Hormonal contraception has been studied extensively since the introduction of the first combined oral contraceptive pills in the early 1960s. Early versions of the pill contained much higher hormone doses than modern formulations, prompting long-term monitoring by researchers and public health agencies.
Large epidemiological studies beginning in the 1970s examined whether long-term hormonal exposure could influence cancer risk. By the early 2000s, evidence suggested a pattern: some cancers appeared slightly more common among pill users, while others occurred less frequently.
In 2005, the International Agency for Research on Cancer formally classified combined oral contraceptives as carcinogenic to humans based on evidence linking them to certain cancers including breast cancer, cervical cancer and liver cancer. Subsequent studies continued to examine these associations using modern lower-dose contraceptive formulations.
A comprehensive literature review published in the **National Institutes of Health database found that combined oral contraceptives remain in the Group 1 classification due to consistent evidence linking them with specific cancers, even though the doses used today are much lower than earlier formulations.
However, long-term population studies also showed that oral contraceptives significantly reduce the risk of ovarian cancer and endometrial cancer, with protective effects lasting decades after use.
This complex balance between increased and decreased cancer risks is why most medical organisations describe hormonal birth control as safe for the majority of users.
Which cancers are linked to hormonal birth control
Research reviewed by major cancer organisations shows that hormonal contraception is associated with modest changes in risk for several cancers.
The **American Cancer Society reports that birth control pills may slightly increase the risk of breast cancer while they are being used. This risk gradually declines after stopping the medication and returns to baseline roughly ten years later.
Cervical cancer risk also increases with long-term use of oral contraceptives. Studies indicate that the risk rises after five or more years of continuous use. However, it decreases after discontinuation.
Some evidence also suggests a possible association between hormonal contraception and liver cancer, although this cancer remains rare in most populations.
Despite these findings, the absolute increase in risk is small. For most individuals the number of additional cases attributed to birth control remains low compared with other lifestyle risk factors.
Cancers that birth control helps prevent
The other side of the scientific evidence often receives less attention in social media discussions. Hormonal birth control substantially reduces the risk of several serious cancers.
The strongest protective effect occurs with ovarian cancer. Research shows that women who use oral contraceptives have a significantly lower lifetime risk of developing ovarian cancer. The reduction in risk can exceed 30 percent and persists for decades after stopping the pill.
Endometrial cancer shows a similar pattern. Hormonal contraceptives lower the risk by preventing excessive growth of the uterine lining, which can otherwise lead to cancer.
Some studies also suggest a protective effect against colorectal cancer, although evidence for this association is less consistent.
According to the **Cancer Research UK, the overall balance of cancer risks and benefits means the pill prevents more cases of cancer than it causes across large populations.
This is why medical organisations continue to recommend hormonal contraception as a safe option for most users.
Understanding risk versus classification
The key misunderstanding driving viral claims lies in the difference between hazard classification and risk assessment.
The IARC classification system evaluates whether something can cause cancer under certain conditions. It does not measure how likely cancer is to occur.
For example, sunlight is also considered carcinogenic because ultraviolet radiation can cause skin cancer. The classification does not imply that normal exposure automatically results in disease.
Similarly, oral contraceptives fall into Group 1 because research demonstrates a causal relationship with certain cancers. The actual risk for individuals depends on factors such as age, genetics, lifestyle, duration of use and overall health.
Medical guidelines therefore evaluate both benefits and risks rather than relying solely on hazard classifications.
What the World Health Organisation actually says
The **World Health Organization continues to state that oral contraceptives are a safe and effective form of birth control when used appropriately. The organisation emphasises that contraceptives are essential tools for reproductive health and family planning.
WHO guidance notes that the benefits include reliable pregnancy prevention, reduced maternal mortality, improved family planning autonomy and treatment for certain medical conditions such as polycystic ovary syndrome and endometriosis.
The organisation also recognises that hormonal contraception may slightly increase the risk of specific cancers while reducing the risk of others. Healthcare providers are encouraged to discuss these factors with patients so individuals can make informed choices.
This balanced interpretation contrasts with viral posts that frame the classification as a warning against using birth control.
Who should be cautious with hormonal contraception
Although birth control pills are safe for most users, certain groups may face higher risks and should consult healthcare professionals before using hormonal contraception.
Individuals with a personal history of breast cancer are typically advised to avoid hormonal contraceptives because the hormones may stimulate tumour growth. Women with certain genetic mutations linked to breast cancer risk may also require personalised guidance.
Other conditions that require careful evaluation include blood clotting disorders, uncontrolled hypertension and liver disease.
Age and smoking status also influence risk profiles. Women over 35 who smoke face higher risks of cardiovascular complications when using combined hormonal contraceptives.
These medical considerations highlight the importance of personalised healthcare rather than generalised social media claims.
Alternative methods of birth control
People who prefer to avoid hormonal contraceptives have several effective alternatives. Modern family planning offers a wide range of methods that vary in mechanism, effectiveness and duration.
Barrier methods such as condoms remain one of the most accessible forms of birth control. Condoms also provide protection against sexually transmitted infections, making them unique among contraceptive methods.
The copper intrauterine device represents a highly effective non-hormonal option. This small device placed in the uterus prevents fertilisation by creating an environment that is hostile to sperm.
Fertility awareness methods involve tracking ovulation cycles and avoiding intercourse during fertile periods. While these approaches can be effective when used correctly, they require consistent monitoring and education.
Permanent contraception options include surgical procedures such as tubal ligation or vasectomy for individuals who no longer wish to have children.
Each method carries different benefits and limitations, making individual lifestyle and health considerations important factors in contraceptive choice.
Dyson Pure Hot+Cool™ HP01 purifying heater + fan (Iron/Silver)
Buy direct from the people who made it
The role of misinformation in health debates
The rapid spread of the “birth control causes cancer” claim illustrates how complex scientific information can become distorted online.
Social media platforms often favour simplified statements or dramatic interpretations that generate engagement. Nuanced scientific conclusions may therefore be condensed into misleading headlines or videos.
Fact-checking organisations and journalists have pointed out that the WHO classification cited in viral posts has existed for many years and was not recently announced.
Health experts emphasise that individuals should rely on medical organisations, peer-reviewed research and qualified healthcare professionals when evaluating claims about medication risks.
Understanding the difference between hazard classification, statistical risk and clinical guidance is essential for interpreting health information accurately.
The future of contraceptive research
Research into safer and more personalised contraceptive methods continues to evolve. Scientists are exploring lower hormone doses, alternative delivery systems and new non-hormonal approaches to pregnancy prevention.
Advances in biotechnology may eventually lead to contraceptives that target reproductive processes more precisely, reducing systemic hormone exposure. Male contraceptive research is also expanding, which could distribute responsibility for pregnancy prevention more evenly between partners.
At the same time, long-term health monitoring remains essential for ensuring that contraceptive methods maintain favourable risk profiles.
Public health experts emphasise that access to reliable contraception remains a critical component of global healthcare. Effective birth control reduces maternal mortality, supports economic stability and allows individuals to plan families according to personal circumstances.
What the evidence means for the average user
For most people the scientific evidence supports a straightforward conclusion. Hormonal birth control carries a small increased risk for certain cancers, but it also provides protection against others and remains a safe option for many users.
The Group 1 classification reflects the presence of evidence linking the pill to some cancers rather than an assessment of how dangerous it is in everyday use.
Medical organisations recommend discussing contraceptive options with healthcare professionals who can consider individual health history, lifestyle and reproductive goals.
Informed decision-making requires examining the full body of evidence rather than relying on isolated statements circulating online.
Understanding the science behind birth control helps ensure that individuals make choices based on accurate information rather than viral misinformation.
Sources:
- World Health Organisation: Oral contraceptives https://www.who.int/news-room/fact-sheets/detail/oral-contraceptives Published on: 23 December 2025
- World Health Organisation: Hormonal Contraception and Post-menopausal Hormonal Therapy https://publications.iarc.who.int/Book-And-Report-Series/Iarc-Monographs-On-The-Identification-Of-Carcinogenic-Hazards-To-Humans/Hormonal-Contraception-And-Post-menopausal-Hormonal-Therapy-1999#:~:text=The%20evaluation%20also%20found%20sufficient,increased%20risk%20for%20endometrial%20cancer.
- American Cancer Society: Birth Control & Cancer: Which Methods Raise, Lower Risk https://www.cancer.org/cancer/latest-news/birth-control-cancer-which-methods-raise-lower-risk.html Published on: March 14, 2025
- Cancer Research UK: Does the contraceptive pill increase risk of cancer? https://www.cancerresearchuk.org/about-cancer/causes-of-cancer/hormones-and-cancer/does-the-contraceptive-pill-increase-cancer-risk
- Community Pregnancy Clinics: Is the Birth Control Pill A Carcinogen? https://communitypregnancyclinic.com/is-the-birth-control-pill-a-carcinogen/
- National Institutes of Health, PubMed Central: Review of the literature on combined oral contraceptives and cancer https://pmc.ncbi.nlm.nih.gov/articles/PMC9377820/#:~:text=Combined%20oral%20contraceptives%20are%20classified%20by%20the,very%20low%20doses%20(10%20and%2020%20mcg).
- EuroNews: Fact-checking viral claims that WHO just listed the contraceptive pill as a carcinogen https://www.euronews.com/my-europe/2025/06/30/fact-checking-viral-claims-that-who-just-listed-the-contraceptive-pill-as-a-carcinogen
______________________
Follow Sweet TnT Magazine on WhatsApp

Every month in 2026 we will be giving away one Amazon eGift Card. To qualify subscribe to our newsletter.
When you buy something through our retail links, we may earn commission and the retailer may receive certain auditable data for accounting purposes.
Recent Articles
- Turtle nesting season in Trinidad and Tobago: A complete public guide to dates, species, locations and responsible viewing
- Birth control and cancer: Understanding the WHO classification and what it means for users
- Unrealised gains tax: The Dutch crypto policy that could reshape global investing
- Why Google is restricting Android sideloading and what it means for the future of the platform
- Skills-first hiring: Why digital credentials are the new global academic currency
You may also like:
Mayo Clinic opens patient information office in Cayman Islands
Prostate cancer: 10 warning signs men should never ignore
Breast Cancer: Help increase survival rates in 6 steps
The link between coffee and cancer
Pepper’s anti-cancer properties: What the science really says
Skin Cancer Awareness Month: People need to get annual skin checks
Universal cancer vaccine developer CEO chats with oncology research leader
Early menopause alert: Why migraines and insomnia may signal higher future health risks
Missed period: 10 common reasons other than you’re pregnant
Pregnant women comfort guide with 10 useful tips
Menstrual cycle: 9 important facts everyone should know
PCOS treatment for fertility, hair growth, clear skin
Erectile dysfunction: 7 early signs men shouldn’t ignore
Belly fat reduced after 6 easy lifestyle changes
Hot flashes: 5 relief tips for women on the go
Trying to conceive: 6 best practices for couples
@sweettntmagazine
Discover more from Sweet TnT Magazine
Subscribe to get the latest posts sent to your email.
Sweet TnT Magazine Trinidad and Tobago Culture

You must be logged in to post a comment.